EVSP UPDATE: What the End of “Duration of Status” Means for J-1 Physicians

---

A guide to the DHS Final Rule replacing Duration of Status (D/S) with a fixed admission period

• Bottom Line
• What’s Changing
• What’s Not Changing
• What Physicians Need to Do Moving Forward
• What This Means, Practically
• What Intealth is Doing
• Open Implementation Questions

Bottom Line

---

• Current J-1 physicians sponsored by Intealth generally do not need to take immediate action.
• The Form I-94 will become the document physicians and programs must track most closely because it controls the physician’s authorized period of stay.
• Physicians in training programs longer than four years may eventually need an Extension of Stay (EOS) filing with U.S. Citizenship and Immigration Services (USCIS) or a new admission period through international travel and reentry.
• Physicians with international travel scheduled during the 60-day transition period ending September 15, 2026, should coordinate with their Intealth Regional Advisor as travel may change how status is recorded.

Duration of Status, or D/S, has allowed J-1 exchange visitors, including physicians in graduate medical education, to remain in the United States as long as they continued to actively participate in their approved program and maintain a valid Form DS-2019. Under D/S, a physician’s authorized stay was governed by the approved program, rather than by a specific expiration date on the Form I-94.

On July 16, 2026, the U.S. Department of Homeland Security (DHS) finalized a rule that replaces D/S with a fixed admission period for F, J, and I nonimmigrants, including J-1 physicians. This is one of the most significant immigration changes to affect graduate medical education in years. Intealth has been preparing for this change and will guide J-1 physicians and training programs through its implementation.

Back to top

What’s Changing

---

• Fixed admission period. Physicians will no longer be admitted for “duration of status.” Each physician’s authorized stay will instead be tied to a fixed, specific end date, up to the length of the training program or four years, whichever is shorter.
• A new filing step. The program end date on the DS-2019 alone will not extend immigration status. To remain in the United States beyond the fixed admission period recorded on Form I-94, a physician must file an EOS with USCIS before that period ends, unless another lawful basis for a new admission period applies.
• Travel may create a new fixed admission period. International travel and reentry may provide a technical alternative to EOS, but this depends on valid travel documents, inspection by Customs and Border Protection (CBP), and agency implementation. Admission remains at the CBP officer’s discretion.
• Travel during the transition period matters. Physicians who travel internationally before September 15, 2026, may receive a new fixed-date I-94 upon reentry, even if they previously held D/S status.

Back to top

What’s Not Changing

---

• Current physicians generally do not need to take immediate action. Physicians currently in D/S generally will keep that status until their program end date, or four years from September 15, 2026, whichever comes first, unless they travel internationally in the meantime.
• Intealth will work to ensure the longest available admission window, where possible, before September 15. For physicians currently in multi-year programs, Intealth will extend their Form DS-2019 program end date before September 15 to help preserve a longer protected window under the transition provisions. For example, a physician in a three-year Internal Medicine residency program will receive a DS-2019 reflecting the full three-year training period.
• Program purpose and eligibility. While the rule changes how long J-1 physicians may be admitted to the United States at one time, it does not change the purpose of the Exchange Visitor Program, the eligibility requirements for sponsorship, or the seven-year maximum duration of participation in the physician category.
• Ongoing obligations. Physicians must continue actively participating in their approved training program, and training programs must continue required reporting of program changes, such as transfers, leaves of absence, and early completion. In addition, those with multi-year DS-2019s will still be required to file an annual application with Intealth. Additional details are forthcoming.
• Intealth’s role. Intealth remains the J-1 sponsor and will continue year-round oversight and compliance monitoring, regardless of how long the DS-2019 is valid.
• No exemption for physicians. DHS considered and explicitly declined a carve-out for J-1 physicians, despite requests from Intealth and others in the medical education community. Intealth will continue discussions with policymakers about the implications of this decision for J-1 physicians, teaching hospitals, and patients.

Back to top

What Physicians Need to Do Moving Forward

---

• Coordinate with an Intealth Regional Advisor before international travel during the 60-day transition period.
• Review the I-94 after every international trip and confirm that the admission information is accurate.
• Watch for updated DS-2019 guidance from Intealth, including information about multi-year DS-2019 issuance.

Back to top

What This Means, Practically

---

• No immediate action is required for most current physicians. Current physicians remain in status under the transition provisions described above.
• A new DS-2019 is coming. Later this summer, Intealth will begin issuing DS-2019s that cover a physician’s full approved training program instead of reissuing a new form every year. This includes currently sponsored physicians who are not in their final year of a training program or in a one-year program.
• The I-94 is the key document to track. The I-94 expiration date controls how long a physician may remain in the United States. If USCIS later approves an EOS, the Form I-797 approval notice will include a new I-94 at the bottom. Under the “last action rule,” that USCIS-issued I-94 supersedes the earlier CBP-issued I-94 and becomes the document of record.
• Longer programs will need a plan. Physicians whose training will run longer than four years will eventually need to file an EOS application with USCIS or receive authorization from CBP for a new admission period. Intealth Regional Advisors will reach out with guidance well before this is needed.
• Work authorization may continue while an EOS is pending. If a physician files a timely EOS application before the fixed admission period ends, existing regulatory provisions allow work authorization to continue for up to 240 days while USCIS adjudicates the application. Intealth is seeking confirmation on how this applies to common transitions, including moving from residency to fellowship or changing institutions. Initial thinking is that the 240 days still applies, even when moving to a new training institution.

Back to top

What Intealth is Doing

---

• Reviewing the Final Rule in full and building implementation guidance for physicians and training programs.
• Preparing to issue multi-year DS-2019s to both newly sponsored and currently sponsored physicians.
• Developing an annual sponsorship review process to maintain required oversight now that the DS-2019 will no longer need annual reissuance in all cases. Details will be communicated before implementation.
• Engaging with DHS, USCIS, CBP, and the broader medical education community to advocate on unresolved implementation questions.

Back to top

Open Implementation Questions

---

• Does travel reset the four-year clock? It is not yet clear whether reentry after international travel grants a full new four-year admission period or only readmits a physician through the original I-94 program end date. Intealth is monitoring how CBP applies the rule in practice.
• How will CBP use Box 4 of the DS-2019? Box 4 identifies the exchange visitor category, including “Alien Physician.” DHS has indicated that CBP should use that category to admit physicians for the full training program, up to four years, but the operational approach is not yet clear.
• Will premium processing expand to EOS filings? Intealth is monitoring whether USCIS will expand premium processing to reduce the risk that adjudication delays disrupt residency and fellowship training cycles.
• Will EOS timelines align with training calendars? Residency, fellowship, and institutional transitions often occur on fixed annual timelines. Intealth is seeking clarification on how EOS adjudication timelines and the 240-day work authorization bridge apply during those transitions.
• Can USCIS absorb the increase in filings? USCIS may see increased EOS filings across F, J, and I populations because the rule does not exempt health care training programs.
• Could Congress still change or void the rule? Because this is classified as a major rule, Congress could still act during the implementation window. While a change is not expected, Intealth is monitoring this closely.

---

Back to top